+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy



Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy



Journal of Hepatology 38(Suppl. 2): 168




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 035159448

Download citation: RISBibTeXText

DOI: 10.1016/s0168-8278(03)80846-2


Related references

Induction doses of interferon-alpha-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial. Journal of Viral Hepatitis 14(2): 89-95, 2007

Re-treatment virologic response in chronic hepatitis C virologic non-responders and responder-relapsers to interferon monotherapy IFN alpha-2b induction followed by combination ribavirin/interferon alpha-2b vs combination ribavirin/interferon alpha-2b. Gastroenterology 120(5 Suppl. 1): A 568, 2001

Combination of interferon alpha and ribavirin in chronic hepatitis C non responders to interferon monotherapy Role of genotype and age. Journal of Hepatology 34(Suppl. 1): 205, 2001

Retreatment with pegylated interferon alpha-2b and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination A prospective randomized pilote study of two regimens Induction versus reg. Journal of Hepatology 40(Suppl 1): 135, 2004

Interferon alpha2a in combination with lamivudine in the treatment of patients with chronic HbeAg hepatitis B non-responders to interferon monotherapy. Journal of Hepatology 36(Suppl. 1): 245, 2002

Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy. Alimentary Pharmacology & Therapeutics. 12(8): 717-723,., 1998

Interferon-alpha-2b + ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-alpha-monotherapy. Zeitschrift für Gastroenterologie 38(2): 159-164, 2000

Combination of low-dose ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic hepatitis C virus-infected non-responders and relapsers after interferon alfa-2a monotherapy. Hepatology 32(4 Pt 2): 353A, 2000

Combination treatment with interferon alpha and ribavirin for chronic hepatitis C patients non responders to interferon alone. Giornale Italiano di Malattie Infettive 4(3): 178-181, May-June, 1998

Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders. Hepato-Gastroenterology 47(36): 1642-1644, 2001

Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy. Hepatology 36(4 Part 2): 362A, 2002

Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis. Hepatology Research 43(10): 1040-1051, 2013

Retreatment of chronic hepatitis C with interferon alpha and ribavirin in non-responders to interferon alpha monotherapy - analysis of the own experience and review of the literature. Zeitschrift fuer Gastroenterologie 36(9): 819-827, Sept, 1998

Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C. Zeitschrift für Gastroenterologie 37(8): 715-723, 1999

Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients. Italian Journal of Gastroenterology and Hepatology 31(6): 472-475, 1999